Abstract: Anthranilic acid was reacted with various substituted 6-bromoquinazolinones in the presence of Cu-powder and anhydrous potassium carbonate in DMF to give acid intermediates (Ullmann Type-II condensation). All these acids were then cyclized in phosphorus oxychloride to give 11-chloropyrimido[4,5-b]acridin-4(3H)-ones. All the synthesized compounds were identified by conventional methods ( 1 H-NMR, IR, elemental analysis) and were screened for their antimicrobial activity on some bacterial and fungal cultures. The results were compared with standard bactericides and fungicides. All the synthesized compounds exhibited moderate antibacterial and antifungal activity.
INTRODUCTION
Acridines are known to be biologically versatile compounds possessing several pharmacological activities, including anticancer, 1,2 antitumor, 3,4 antiviral, 5 antimicrobial, [6] [7] [8] antimalarial, 9 analgesic and anti-inflammatory, 10 etc. In the course of ongoing work, the antimicrobial sensitivity of pyrimido acridine derivatives, synthesized by Ullmann Type-II condensation, 11, 12 of halogenated quinazolinones with anthranilic acid followed by cyclization using phosphorus oxychloride are reported. The antimicrobial activity of the synthesized derivatives was studied by varying the group at the 3-position of the pyrimido ring system. All the synthesized compounds showed moderate antibacterial and antifungal activity against the tested species.
General procedure for the synthesis of compounds 4a-m
The compounds 4a-m were prepared by cyclization of compounds 3a-m by the following procedure. 15 Compounds 3a-m (0.01 mol) were charged into a 250 ml round bottom flask equipped with a condenser, in a water bath, and POCl 3 (0.03 mol) was slowly added with shaking. The temperature was raised to 40-45°C. Afterwards the temperature was raised, to 90-95°C and maintained for 4 h with occasionally shaking. The excess POCl 3 was distilled off under vacuum. After cooling, the residue was poured into a well-stirred mixture of aqueous ammonia, CHCl 3 and ice. The chloroform layer was extracted, dried over anhydrous Na 2 SO 4 and filtered. The excess of solvent was removed by distilation to obtain 3-hydropyrimido acridine compounds 4a-m, which were recrystallized from CHCl 3 . Antibacterial activity [16] [17] [18] [19] The agar diffusion technique was employed for the determination of the antibacterial activity of all the synthesized compounds 3a-m and 4a-m. The test organism Bacillus subtilis (gram positive), Bacillus cereus (gram positive) and Escherichia coli (gram negative) were inoculated into sterile nutrient broth (Hi-media, Mumbai) and incubated at 37°C for 24 h. The testing was carried out at a concentration of 1000 ppm using DMF as solvent. The results were compared with the commercial antibacterial norfloxacin and ampicillin. The inhibitory activity of each compound was expressed as the diameter of the inhibition zone (mm). All the compounds were found to be moderately active against the tested species.
2-{[3,4-Dihydro-3-(4-methoxycarbonylphenyl)-4-oxo-2-phenylquinazolin-6-yl]amino}benzoic

2-{[3,4-Dihydro-3-(4-methylphenyl)-4-oxo-2-phenylquinazolin-6-yl]amino}benzoic
2-{[3-(4-Ethoxyphenyl)-3,4-dihydro-4-oxo-2-phenylquinazolin-6-yl]amino}benzoic
2-{[3-(4-Dimethylaminophenyl)-3,4-dihydro-4-oxo-2-phenylquinazolin-6-yl]amino}benzoic acid
Characterization of compounds 4a-m
4-(11-Chloro-3,4-dihydro-4-oxo-2-phenylpyrimido[4,5-b]acridin-3-yl)benzoic
3-(4-Acetylphenyl)-11-chloro-3,4-dihydro-2-phenylpyrimido[4,5-b]acridin-4-one
11-Chloro-3,4-dihydro-3-(4-methoxyphenyl)-2-phenylpyrimido[4,5-b]acridin-4-one
Antifungal activity 20, 21 The compounds 3a-m and 4a-m were screened for their antifungal activity against Aspergillius niger and Fusarium oxysporum by the Plate poison technique. The assay was carried out at a concentration of 2000 ppm using DMF as the control. A commercial fungicide griseofulvin was also tested under similar condition to compare the results. The percentage inhibition of growth of fungus colony is given by the following expression, (%) inhibition = [C-T/C]´100, where C is the diameter of the fungus colony (mm) in the control after 96 h and T is diameter of fungus colony (mm) in the presence of the test chemical after 96 h. All the synthesized compounds exhibited significant activity against the tested species.
RESULTS AND DISCUSSION
The Ullmann Type-II condensation of various 6-bromo-2-phenyl-3-(4-substituted phenyl)-4-(3H)quinazolinones with anthranilic acid resulted in the formation of the intermediate acid compounds 3a-m. These underwent cyclization in presence of phosphorus oxychloride to give the 3-hydropyrimidoacridine derivatives 4a-m (Scheme 1).
The IR spectra of compounds 3a-m showed a band a 3120-3274 cm -1 due to the -NH-group. In the 1 H-NMR spectrum of compounds 3a-m, a peak due to the carboxylic acid group appeared and the -NH-proton was characterized by D 2 O exchange. The other protons resonated at the expected field.
Cyclization of compounds 3a-m in presence of POCl 3 gave acridine derivatives which were characterized by their 1 H-NMR spectral data. The absence of any peak due to -NH-protons and carboxylic group indicated completion of the cyclization. The IR band at 695-709 cm -1 shows the presence of the C-Cl group, which is further evidence for the cyclic structure of compounds 4a-m.
Compounds 3a-m and 4a-m were tested against three microorganism species at a concentration of 1000 ppm (Tables I and II) . The observed results of the antibacterial screening indicate that compounds 3a, 3b, 3c, 3k and 3l show moderate
